{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:20:40Z","timestamp":1758759640352,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ren\u00e9 Bar\u00f3n Foundation"},{"name":"National Academy of Medicine"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.thromres.2020.11.029","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:04:56Z","timestamp":1606561496000},"page":"49-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Type 2N von Willebrand disease: Is it always a recessive trait?"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-1796","authenticated-orcid":false,"given":"Adriana In\u00e9s","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4683-7899","authenticated-orcid":false,"given":"Liliana Carmen","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-1269","authenticated-orcid":false,"given":"Juvenal","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-4379","authenticated-orcid":false,"given":"Carlos Daniel","family":"De Brasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lucila","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Marta","family":"Casinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-1057","authenticated-orcid":false,"given":"Alicia Noem\u00ed","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-9217","authenticated-orcid":false,"given":"Anal\u00eda","family":"S\u00e1nchez-Luceros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.11.029_bb0005","doi-asserted-by":"crossref","unstructured":"Favaloro EJ. Rare forms of von Willebrand disease. Ann. Transl. Med. 6 (2018) 345\u2013355. doi:10.21037\/atm.2018.09.10.","DOI":"10.21037\/atm.2018.09.10"},{"key":"10.1016\/j.thromres.2020.11.029_bb0010","doi-asserted-by":"crossref","unstructured":"Woods AI, Kempfer AC, Paiva J, Blanco AN, S\u00e1nchez-Luceros A, L\u00e1zzari MA. Diagnosis of von Willebrand disease in Argentina: a single institution experience. Ann. Blood. 2 (2017) 22. doi:10.21037\/aob.2017.12.04.","DOI":"10.21037\/aob.2017.12.04"},{"key":"10.1016\/j.thromres.2020.11.029_bb0015","doi-asserted-by":"crossref","unstructured":"Leyte A, Verbeet MP, Brodniewicz-Proba T, Van Mourik JA, Mertens K. The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochem. J. 257 (1989) 679\u2013683. doi:1042\/bj2570679.","DOI":"10.1042\/bj2570679"},{"key":"10.1016\/j.thromres.2020.11.029_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/hae.13366","article-title":"Type 2N von Willebrand disease: characterization and diagnostic difficulties","volume":"24","author":"Casonato","year":"2018","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2020.11.029_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.thromres.2020.11.029_bb0030","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood-2015-06-652073","article-title":"FVIII-VWF dos-\u00e0-dos","volume":"126","author":"Krishnaswamy","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.11.029_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.11.029_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0029-7844(95)00062-V","article-title":"A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss","volume":"85","author":"Janssen","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2020.11.029_bb0045","first-page":"692","article-title":"Definition of major bleeding in clinical investigation of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"Scientific and Standardization Committee Communication. J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.11.029_bb0050","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.11112","article-title":"Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects","volume":"92","author":"Rossetti","year":"2007","journal-title":"Haematologica."},{"author":"Srivastava","key":"10.1016\/j.thromres.2020.11.029_bb0055"},{"key":"10.1016\/j.thromres.2020.11.029_bb0060","doi-asserted-by":"crossref","unstructured":"Goodeve AC, Al-Baba S, Panayi M. Mutations leading to reduced von Willebrand factor binding to factor VIII are uncommon among patients referred for type 2N von Willebrand disease genetic analysis. Platelets. 20 (2009) (S1) S14\u2013O16. doi:https:\/\/doi.org\/10.1080\/09537100903170182.","DOI":"10.1080\/09537100903170182"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482030637X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482030637X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:43:06Z","timestamp":1758735786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482030637X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":12,"alternative-id":["S004938482030637X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.11.029","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2N von Willebrand disease: Is it always a recessive trait?","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}